Insight Molecular Diagnostics Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Insight Molecular Diagnostics Inc. (IMDX), sourced directly from SEC EDGAR and updated as new filings are accepted.
Quick Answer
Are IMDX insiders buying or selling?
Insight Molecular Diagnostics Inc. insiders reported 66 open-market buys ($128.6M) and 7 sells ($16.4M) across 73 Form 4 filings — a net buying position of $112.2M.
Source: SEC EDGAR Form 4
Key Statistics (as of Apr 27, 2026)
Insider sentiment
Net buyingNet insider flow of $112.2M in net buying. 1 insider buy in the last 90 days.
Recent IMDX insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 27, 2026 | Neal C Bradsher | 10% Owner | Purchase | 570.2K | $3.56 | $2.0M |
| Apr 20, 2026 | Neal C Bradsher | 10% Owner | Purchase | 182.9K | $3.57 | $652.9K |
| Feb 13, 2026 | Neal C Bradsher | 10% Owner | Purchase | 521.7K | $5.75 | $3.0M |
| Feb 12, 2025 | Andrea S. James | Chief Financial Officer | Purchase | 97.6K | $2.05 | $200.0K |
| Feb 11, 2025 | SMITH PATRICK W | 10% Owner | Purchase | 1.1M | $2.05 | $2.2M |
| Feb 11, 2025 | Neal C Bradsher | 10% Owner | Purchase | 5.2M | $2.05 | $10.6M |
| Feb 4, 2025 | SMITH PATRICK W | 10% Owner | Purchase | 915 | $2.01 | $1.8K |
| Jan 31, 2025 | SMITH PATRICK W | 10% Owner | Purchase | 4.2K | $2.01 | $8.4K |
| Jan 15, 2025 | SMITH PATRICK W | 10% Owner | Purchase | 16.1K | $2.12 | $34.1K |
| Dec 28, 2024 | SMITH PATRICK W | 10% Owner | Purchase | 90.2K | $2.13 | $192.2K |
| Dec 26, 2024 | Arno Andrew | Director | Purchase | 12.5K | $2.11 | $26.4K |
| Dec 9, 2024 | Andrea S. James | Chief Financial Officer | Purchase | 20.0K | $2.29 | $45.8K |
| Oct 4, 2024 | Andrea S. James | Chief Financial Officer | Purchase | 33.7K | $2.97 | $100.0K |
| Oct 4, 2024 | Neal C Bradsher | 10% Owner | Purchase | 1.3M | $2.95 | $3.9M |
| Apr 15, 2024 | Neal C Bradsher | 10% Owner | Purchase | 2.4M | $2.92 | $7.1M |
| Apr 15, 2024 | Josh Riggs | CEO and President | Purchase | 3.4K | $2.95 | $10.0K |
| Apr 15, 2024 | Arno Andrew | Director | Purchase | 33.9K | $2.95 | $100.0K |
| Jun 16, 2023 | Alfred D Kingsley | Director | Purchase | 30.0K | $0.21 | $6.4K |
| Apr 7, 2023 | PURA VIDA INVESTMENTS, LLC | 10% Owner | Purchase | 663.0K | $0.30 | $200.0K |
| Apr 6, 2023 | Neal C Bradsher | 10% Owner | Purchase | 26.8M | $0.30 | $8.1M |
| Dec 28, 2022 | Arno Andrew | Director | Purchase | 250.0K | $0.35 | $87.9K |
| Dec 28, 2022 | John Peter Gutfreund | Director | Purchase | 75.0K | $0.33 | $24.7K |
| Dec 27, 2022 | Alfred D Kingsley | Director | Purchase | 25.0K | $0.29 | $7.1K |
| Aug 19, 2022 | Andrew J. Last | Director | Purchase | 20.0K | $0.87 | $17.4K |
| Aug 19, 2022 | Arno Andrew | Director | Purchase | 15.0K | $0.90 | $13.5K |
Showing the 25 most recent of 73 Form 4 filings for Insight Molecular Diagnostics Inc..
Most active IMDX insiders
- Neal C Bradsher16 filings
- Arno Andrew7 filings
- Ronald Asbury Andrews7 filings
- Levine Mitchell S6 filings
- Alfred D Kingsley5 filings
Ask anything about IMDX insider activity
Use Trabud's AI agent to query Insight Molecular Diagnostics Inc.'s Form 4 history in plain English — "Show me IMDX CEO purchases this year" or compare it against any other ticker.
Open the AI agentIMDX insider trading FAQ
Are Insight Molecular Diagnostics Inc. insiders buying or selling?
Across 73 SEC Form 4 filings, Insight Molecular Diagnostics Inc. (IMDX) insiders reported 66 open-market purchases totaling $128.6M and 7 sales totaling $16.4M. That is a net buying position of $112.2M.
How many insiders trade IMDX stock?
21 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Insight Molecular Diagnostics Inc.. The most recent filing was accepted on Apr 27, 2026.
Where does Trabud get IMDX insider trading data?
All IMDX insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.